← Latest Filings
D
Douglas Earl Martin
SVP, General Counsel
Open-market buys
0
$0 total
Open-market sells
1
$63K total
Tracking since
Aug 2026
Activity timeline
Open-market sale — $63K
Allogene Therapeutics, Inc. · Aug 21, 2026
Open-market trades from the last two years.
Holdings as last reported
488,267 Common Stock in ALLO
Held directly · as of 2026-08-21
Companies touched
Allogene Therapeutics, Inc.
CIK 0001737287
